caprylates has been researched along with Virus Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franks, L; Hotta, J; Korneyeva, M; Lebing, W; Petteway, SR; Rosenthal, RS | 1 |
| Hotta, JA; Lebing, W; Lee, DC; Li, H; Petteway, S; Remington, KM; Stenland, C; Storms, RE; Trejo, SR | 1 |
| Lebing, W; Paul, HI; Remington, KM; Schreiner, C | 1 |
| Abshire, TC; Angiolillo, A; Brenner, B; Bussel, JB; Eldor, A; Gillis, S; Kelleher, J; Kelton, JG; Kulkarni, R; Varon, D | 1 |
1 trial(s) available for caprylates and Virus Diseases
| Article | Year |
|---|---|
IGIV-C, a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action, and impact on quality of life.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Caprylates; Child; Child, Preschool; Double-Blind Method; Female; Humans; Immunoglobulins, Intravenous; Incidence; Infant; Male; Middle Aged; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Quality of Life; Sterilization; Treatment Outcome; Virus Diseases | 2004 |
3 other study(ies) available for caprylates and Virus Diseases
| Article | Year |
|---|---|
Enveloped virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates.
Topics: Albumins; Blood-Borne Pathogens; Caprylates; Chromatography, Gas; Chromatography, Ion Exchange; Detergents; HIV-1; Hydrogen-Ion Concentration; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Kinetics; Lipids; Nephelometry and Turbidimetry; Sodium Cholate; Solvents; Sterilization; Temperature; Time Factors; Virus Diseases; Virus Inactivation; Viruses | 2002 |
Evaluation of virus and prion reduction in a new intravenous immunoglobulin manufacturing process.
Topics: Caprylates; Chemical Precipitation; Chromatography; Disinfection; Drug Contamination; Drug Industry; Filtration; Humans; Immunoglobulins, Intravenous; Manufactured Materials; Prion Diseases; Prions; Virus Diseases; Viruses | 2003 |
Properties of a new intravenous immunoglobulin (IGIV-C, 10%) produced by virus inactivation with caprylate and column chromatography.
Topics: Animals; Bacterial Infections; Caprylates; Chemical Precipitation; Chromatography; Disinfection; Drug Contamination; Drug Industry; Humans; Immunoglobulins, Intravenous; Mice; Survival Rate; Virus Diseases; Viruses | 2003 |